Two of our DVRs and a DMR for lymphatic–hematopoietic cancers were annotated to genes HOXA2 and HOXA-AS3 and overlapped with promoters of the HOX family, whose aberrant expression levels have been related to several cancers [41–45]. This evidence concerns the gene HOXA2 and cancer.